We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held Equity + Options
1
year
Top 10 Avg Time Held Equity + Options
2.3
years
Top 20 Avg Time Held Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
Sally Beauty Holdings
SBH
$1.56B
| $16.3M | 0.01% |
1,153,626
+602,094
| +109% | +$8.12M |
2025 Q2
4 quarters
|
|
802
Xerox
XRX
$324M
| $16.2M | 0.01% |
5,188,512
+1,494,031
| +40% | +$3.73M |
2024 Q3
7 quarters
|
|
803
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.32B
| $16.2M | 0.01% |
105,254
+56,248
| +115% | +$9.41M |
2025 Q4
2 quarters
|
|
804
CBL Properties
CBL
$1.53B
| $16.2M | 0.01% |
+305,205
| New | +$14.1M |
2026 Q2
0 quarters
|
|
805
Stryker
SYK
$113B
| $16.1M | 0.01% |
51,116
-579,120
| -92% | -$182M |
2024 Q1
9 quarters
|
|
806
CALL
Goldman Sachs
GS
$257B
| $16.1M | 0.01% |
+15,900
| New | +$15.5M |
2026 Q2
0 quarters
|
|
807
Workiva
WK
$4.1B
| $16.1M | 0.01% |
331,483
+324,865
| +4,909% | +$16.7M |
2025 Q4
2 quarters
|
|
808
Core & Main
CNM
$7.74B
| $16M | 0.01% |
332,321
+308,396
| +1,289% | +$15.2M |
2026 Q1
1 quarter
|
|
809
Ultrapar
UGP
$8.31B
| $16M | 0.01% |
3,193,062
+1,431,153
| +81% | +$7.87M |
2024 Q1
9 quarters
|
|
810
Darling Ingredients
DAR
$9.68B
| $16M | 0.01% |
293,397
-357,403
| -55% | -$21.3M |
2020 Q2
24 quarters
|
|
811
Goosehead Insurance
GSHD
$1.1B
| $16M | 0.01% |
330,416
+277,880
| +529% | +$11.5M |
2025 Q4
2 quarters
|
|
812
NexGen Energy
NXE
$5.61B
| $15.9M | 0.01% |
1,696,238
-3,072,811
| -64% | -$34.9M |
2023 Q4
10 quarters
|
|
813
Harrow
HROW
$1.02B
| $15.7M | 0.01% |
369,435
-275,483
| -43% | -$10.2M |
2025 Q1
5 quarters
|
|
814
CALL
Salesforce
CRM
$198B
| $15.6M | 0.01% |
99,700
+5,200
| +6% | +$914K |
2024 Q4
6 quarters
|
|
815
ESCO Technologies
ESE
$6.45B
| $15.6M | 0.01% |
44,509
-2,835
| -6% | -$887K |
2025 Q3
3 quarters
|
|
816
Kodiak Gas Services
KGS
$4.77B
| $15.6M | 0.01% |
207,204
-35,625
| -15% | -$2.42M |
2026 Q1
1 quarter
|
|
817
Albemarle
ALB
$11.3B
| $15.5M | 0.01% |
115,155
+71,721
| +165% | +$12.6M |
2025 Q4
2 quarters
|
|
818
Sensient Technologies
SXT
$5.69B
| $15.5M | 0.01% |
126,112
-145,048
| -53% | -$16.1M |
2024 Q4
6 quarters
|
|
819
Relmada Therapeutics
RLMD
$331M
| $15.5M | 0.01% |
2,246,839
-2,234,767
| -50% | -$15.6M |
2025 Q2
4 quarters
|
|
820
Northrop Grumman
NOC
$73.9B
| $15.5M | 0.01% |
+30,517
| New | +$17.6M |
2026 Q2
0 quarters
|
|
821
Ralliant Corp
RAL
$7.36B
| $15.5M | 0.01% |
210,377
+111,040
| +112% | +$6.19M |
2025 Q3
3 quarters
|
|
822
Grindr
GRND
$2.45B
| $15.5M | 0.01% |
1,077,129
-489,951
| -31% | -$6.34M |
2025 Q4
2 quarters
|
|
823
Powell Industries
POWL
$6.02B
| $15.5M | 0.01% |
+54,007
| New | +$14.7M |
2026 Q2
0 quarters
|
|
824
Medpace
MEDP
$17.3B
| $15.5M | 0.01% |
29,182
+19,329
| +196% | +$8.92M |
2024 Q4
6 quarters
|
|
825
Aon
AON
$62.1B
| $15.5M | 0.01% |
+46,582
| New | +$15M |
2026 Q2
0 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.